Mirum Pharmaceuticals Inc (MIRM)
25.84
+0.24
(+0.94%)
USD |
NASDAQ |
May 03, 16:00
25.82
-0.02
(-0.08%)
After-Hours: 20:00
Mirum Pharmaceuticals Free Cash Flow (Quarterly): -21.62M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -21.62M |
| September 30, 2023 | -18.22M |
| June 30, 2023 | -17.40M |
| March 31, 2023 | -33.82M |
| December 31, 2022 | -34.51M |
| September 30, 2022 | -26.04M |
| June 30, 2022 | -20.19M |
| March 31, 2022 | -39.67M |
| December 31, 2021 | -52.15M |
| September 30, 2021 | -34.22M |
| Date | Value |
|---|---|
| June 30, 2021 | -40.20M |
| March 31, 2021 | -25.21M |
| December 31, 2020 | -36.31M |
| September 30, 2020 | -17.50M |
| June 30, 2020 | -17.05M |
| March 31, 2020 | -18.45M |
| December 31, 2019 | -13.76M |
| September 30, 2019 | -15.39M |
| June 30, 2019 | -8.017M |
| March 31, 2019 | -2.47M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-52.15M
Minimum
Dec 2021
-8.017M
Maximum
Jun 2019
-25.77M
Average
-21.62M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -3.985M |
| Sarepta Therapeutics Inc | -284.52M |
| Puma Biotechnology Inc | 10.41M |
| Reneo Pharmaceuticals Inc | -19.78M |
| Tharimmune Inc | -1.415M |